Holen Sie sich die Stockscreener-App
41.45
2.86%
1.0655
Schlusskurs vom Vortag:
$40.38
Offen:
$40.01
24-Stunden-Volumen:
896.90K
Relative Volume:
0.55
Marktkapitalisierung:
$6.16B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
19.93
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
-4.54%
1M Leistung:
-12.04%
6M Leistung:
-38.43%
1J Leistung:
-54.31%
1-Tages-Spanne:
$39.88
$41.95
1-Wochen-Bereich:
$39.88
$44.00
52-Wochen-Spanne:
$39.88
$91.86
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
41.45 | 6.16B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
131.62 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.58 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
374.08 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.55 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.03 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker installs novel MRI polarizer at UCSF for cancer research - Investing.com
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR – Company AnnouncementFT.com - Financial Times
Bruker stock hits 52-week low at $42.68 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $42.68 amid market challenges - Investing.com
Is Bruker Corporation (BRKR) an Oversold Value Stock to Buy According to Hedge Funds? - Insider Monkey
Bruker : Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes - MarketScreener
Bruker stock hits 52-week low at $44 amid market challenges By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $44 amid market challenges - Investing.com
Bruker Corporation (BRKR): Among Michael Burry’s Top Holdings - Insider Monkey
Based On Its ROE, Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock? - Yahoo Finance
Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing - Insider Monkey
Bruker Co. (NASDAQ:BRKR) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
FY2027 Earnings Estimate for Bruker Issued By Zacks Research - Defense World
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail - Yahoo Finance
Bruker Co. (NASDAQ:BRKR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Bruker at Leerink Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Bruker at Leerink Conference: Navigating Challenges and Opportunities - Investing.com
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds By Investing.com - Investing.com South Africa
Bruker stock hits 52-week low at $45.13 amid market challenges - Investing.com Australia
Bruker Corp’s chief accounting officer buys $23,697 in stock - Investing.com India
Bruker at Barclays Healthcare Conference: Navigating Headwinds and Tailwinds - Investing.com
US Bancorp DE Has $694,000 Stock Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Proficio Capital Partners LLC Invests $608,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex
Zacks Research Predicts Bruker’s Q4 Earnings (NASDAQ:BRKR) - Defense World
Bruker Corp. to Host Earnings Call - ACCESS Newswire
Bruker at TD Cowen Conference: Strategic Growth in Healthcare - Investing.com
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM - Yahoo Finance
Bank of New York Mellon Corp Grows Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Is Bruker Corporation (BRKR) the Best Medical Technology Stock to Buy According to Analysts? - Yahoo Finance
BRUKER CORP SEC 10-K Report - TradingView
Truist Financial Corp Invests $910,000 in Bruker Co. (NASDAQ:BRKR) - Defense World
Sanctuary Advisors LLC Increases Stake in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker launches advanced 3D X-ray microscope - Investing.com
Could This New X-Ray Technology Transform Scientific Research? Bruker's X4 POSEIDON Promises 10X Better Resolution - StockTitan
Bruker stock hits 52-week low at $48.04 amid market challenges - Investing.com
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications – Company AnnouncementFT.com - Financial Times
Bruker Corporation (BRKR) is on Detractors’ list of The London Company SMID Cap Strategy - Yahoo Finance
What Makes Bruker Corporation (BRKR) a Lucrative Investment? - Yahoo Canada Finance
User - Financial Content
There May Be Reason For Hope In Bruker's (NASDAQ:BRKR) Disappointing Earnings - Yahoo Finance
Bruker announces advances in proteomics technology - Investing.com
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO – Company AnnouncementFT.com - Financial Times
BRKRBruker Corp Latest Stock News & Market Updates - StockTitan
Bruker Corporation appoints new board member By Investing.com - Investing.com South Africa
Bruker Corporation appoints new board member - Investing.com
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025 - Quantisnow
Bruker Appoints Laura Francis to its Board of Directors - Yahoo Finance
Bruker Announces Quarterly Dividend - Yahoo Finance
Frank Laukien Buys Handful Of Shares In Bruker - Yahoo Canada Finance
Four Major Healthcare Conferences: Where Bruker Will Share Its 2025 Vision - StockTitan
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.76%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):